A new survey by PricewaterhouseCoopers indicates that Asia is likely to become the top market in the world for medicines, and a major center for research and manufacturing. Of the 185 executives from domestic and multinational companies (MNCs) in Asia who were surveyed, 58% believe that the pharmaceutical industry will shift its focus to Asia. […]
In April, President Vladimir Putin announced the Presidential Nanotechnology Initiative. At least RUB 28 billion ($1.1 billion) in government funding will be allocated for the initiative through 2010; some funds will go to the purchasing new laboratory equipment. According to the Russian government, RUB 150 billion ($5.8 billion) has already been invested in nanotechnology. Putin […]
In the first of IBO’s twice yearly surveys of major new or planned laboratories, Asia and India as well as a number of hefty investments by universities throughout the US are highlighted. India’s growing market, lower costs and educated workforce have attracted increased investments in new laboratories in recent years. Not surprisingly, a number of […]
The Chinese government has announced a far-reaching, 15-year program to modernize traditional Chinese medicine (TCM). Already, the Chinese government has allotted CNY 1 billion ($130 million) for TCM R&D, and the total budget over the next five years is expected to range between CNY 3.7 billion and CNY 4.4 billion. This new program, which is […]
According to data compiled in a 2006 study by the Confederation of the Food and Drink Industries of the EU (CIAA), the food and beverage industry was the largest manufacturing sector in the EU in 2005. Its sales grew 2.6% to €836 billion ($1.2 trillion) to represent 13.6% of EU manufacturing sales. In 2005, the […]
Functional Genomics in Norway (FUGE), which was established in 2002 to build a knowledge base and infrastructure that would help Norway to work at the frontiers of functional genomics research has announced a budget of NOK 920 million ($154.4 million) for 2007–2011, of which NOK 420 million ($70.5 million) is now available for funding projects. […]
Following up on IBO’s examination of manufacturing trends in the industry (see IBO 3/31/07), Singapore continues to be a popular location for manufacturing facilities. This February, Fluidigm launched a Biomedical Product Development Center in Singapore, which will be used for R&D of a new biochip fluorescence reader and biochip loader. Bio-Rad unveiled a 20,000 square […]
If you open the paper, it is hard not to read about a major company establishing manufacturing facilities in a foreign country. Intel’s announcements about facilities in China and Vietnam are recent examples of this phenomenon. Clearly, Asia has been the most attractive region for locating manufacturing facilities for industry in general. However, the instrument […]
China plans to dramatically increase agricultural biotechnology spending to guarantee its food supply. Although a final budget has yet to be approved, spending is set to increase five times its current level, according to Zhang Liang Chen, president of the Agricultural University of China. According to Jikun Huang, director of the Center for Chinese Agricultural […]
The United Kingdom’s fiscal 2007 budget, announced on March 21, increased resources for scientific research. The budget specified a 2.5% average annual increase in real terms in science spending to £6.287 billion ($12.267 billion) by 2010–11. In 2007–08, UK science spending totals £5.397 billion, including £3.383 billion for the Department for Trade and Industry and […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
